Literature DB >> 1689547

Effect of CCK antagonist L 364718 on meal-induced pancreatic secretion in rats.

M F O'Rourke1, R D Reidelberger, T E Solomon.   

Abstract

The specific cholecystokinin (CCK)-receptor antagonist L 364718 was used to examine the role of CCK in meal-induced pancreatic secretion. Unanesthetized rats with gastric, jugular vein, bilepancreatic, and duodenal cannulas were used; bile-pancreatic juice was recirculated. Basal amylase secretion (30% of maximal) was not inhibited by L 364718 doses of 0.5 or 2 mg/kg intravenously. L 364718 (0.02 to 2 mg/kg) caused dose-related inhibition of the maximal amylase response to CCK-8 (200 pmol.kg-1.h-1), with greater than 80% inhibition at doses greater than or equal to 0.5 mg/kg. L 364718 (0.5 mg/kg) shifted the dose-response curve to CCK-8 (25-3,200 pmol.kg-1.h-1) to the right (ED50 increased 10-fold) but did not alter maximal amylase output consistent with competitive inhibition of CCK in vivo. Ingestion of liquid food significantly increased amylase output threefold above basal. L 364718 (0.5 mg/kg) completely blocked this response. These results suggest that although CCK does not regulate basal pancreatic enzyme secretion, it is the primary mediator of pancreatic enzyme secretion in response to a liquid meal.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1689547     DOI: 10.1152/ajpgi.1990.258.2.G179

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  2 in total

Review 1.  Perspectives of CCK antagonists in pancreatic research. Part II. Experimental studies.

Authors:  T Takács; A Pap
Journal:  Int J Pancreatol       Date:  1991-09

2.  Nonparallel patterns of circadian pancreatic and biliary secretions in fasting rats.

Authors:  B Glasbrenner; L Dürrschnabel; M Büchler; P Malfertheiner
Journal:  Int J Pancreatol       Date:  1992-06
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.